|Day Low/High||78.21 / 79.34|
|52 Wk Low/High||73.81 / 100.23|
What differentiated traders who were injured yesterday from those able to whether a sudden storm? Diversification.
Stock futures are lower.
U.S. stock futures fall as earnings from Amazon.com disappoint.
Wall Street's first glimpse at the second quarter.
Remarkable data was released from Vertex's triple regiment combination trials.
Tech companies aren't the only ones seeing their shares rise this year.
Investors need to focus on earnings and not be distracted by the circus in Washington, Jim Cramer says.
Oil prices are tumbling down. Bad news for companies and petro states, but great news at the pump and for these ten industries...
The approval of Johnson & Johnson's psoriasis treatment will have an adverse impact on Valeant in the second half of 2017, Wells Fargo argued.
Players include Apple, Google, Microsoft and Samsung.
Samsung's Bioepis unit seeks final approval in Europe of a rheumatoid arthritis drug to compete with Humira.
Jim Cramer doesn't buy the backlash against Amazon. He says Prime is a very powerful tool and an irresistible bargain.
Jim Cramer is bullish on Citigroup, Zoetis, Idexx Labs, AbbVie, Nucor, and Alexion.
The main thrust of the order appears to be easing regulatory hurdles to drug approvals, which could lower the cost of bringing new treatments to market and thus lower prices.
Epizyme sank almost 20% since their last earnings report, but recent developments show positive data from one of its keynote drugs, Tazemetostat
AbbVie's June rally has now driven shares past the 2016 high.
Stocks are narrowly mixed on Friday, putting the S&P 500 and Nasdaq at risk of snapping a six-day winning streak.
Elliott's previous successes in the healthcare space bode well for its chances at athena.
The drug is responsible for more than 60% of AbbVie's top line.
Jim Cramer is bullish on AbbVie, Broadcom, Enbridge Energy Partners, and Commercial Vehicle Group.
Jim Cramer says investors are migrating toward sectors likely to have the biggest upside in the second half.
Stocks move mostly lower on Thursday after the House passes a bill to repeal and replace the Affordable Care Act.
Cramer shares his views on which is better: Amazon or Alphabet, and discusses the domino effect when oil falls.
Jim Cramer says this market is strong enough to withstand falling oil prices and a tax plan that will face a lot of obstacles.
A guide to keep track of all the companies reporting first quarter financial results today -- making sense of what's important and disregarding what's not.
Stocks hold onto slight to modest gains Thursday afternoon after positive earnings help to offset a slump in crude oil prices and a decline in energy names.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.